Rameda to distribute 0.52-for-1 bonus shares in September
Updated 9/5/2023 9:27:00 AM
Arab Finance: The Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA) will distribute 0.52253-for-1 bonus shares to shareholders as of September 21st, the company stated on September 5th.
Shareholders of record date on September 20th will be entitled to receive the stock dividends.
The bonus shares distribution comes as part of the company’s decision to increase its issued capital to EGP 380 million from EGP 252.112 million, as the increase amounts to EGP 127.887 million and is distributed over 1.520 billion shares at a par value of EGP 0.25.
During the first half (H1) of 2023, the firm saw a 6.87% year-on-year (YoY) decline in consolidated net profit excluding minority interest, recording EGP 115.67 million.
Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals.
It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.
Related News
